Google-Backed 23andMe Asks FDA to Clear DNA Evaluation Service

23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, sought U.S. regulatory approval for a genetic testing service that may help people assess their risk for developing cancer and Alzheimer’s.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.